From: M2PP: a novel computational model for predicting drug-targeted pathogenic proteins
Disease name | Rank | Target name | Have CDs | Evidence | Disease name | Rank | Target name | Have CDs | Evidence |
---|---|---|---|---|---|---|---|---|---|
Lung cancer | 1 | TNF | Yes | [40] | Colon cancer | 4 | ESR1 | Yes | [46] |
2 | IL1B | Yes | [47] | 5 | ACE | Yes | |||
3 | CTNNB1 | Yes | 6 | CYP2A6 | Yes | [52] | |||
4 | ESR1 | Yes | [53] | 7 | CA1 | Yes | [54] | ||
5 | MMP9 | Yes | [55] | 8 | PIK3CA | Yes | [56] | ||
6 | MAPK3 | Yes | [57] | 9 | PLAU | Yes | [58] | ||
7 | SOD1 | Yes | [59] | 10 | CYP2E1 | Yes | [60] | ||
8 | AKT1 | Yes | [61] | Leukemia | 1 | VEGFA | Yes | [43] | |
9 | MAPK1 | Yes | [62] | 2 | HIF1A | Yes | [63] | ||
10 | PTGS2 | Yes | [64] | 4 | TGM2 | Yes | [65] | ||
Breast cancer | 1 | IL2 | Yes | [41] | 5 | JUN | Yes | [66] | |
2 | NR3C1 | Yes | [67] | 6 | TP53 | Yes | [68] | ||
3 | PON1 | Yes | 7 | AKT1 | Yes | [71] | |||
4 | JAK2 | Yes | [72] | 8 | GSTP1 | Yes | |||
5 | ICAM1 | Yes | [75] | 9 | CDK4 | Yes | [76] | ||
6 | VEGFA | Yes | [77] | 10 | SMO | Yes | [78] | ||
7 | CCL2 | Yes | [79] | Lymphoma | 1 | CHKA | Yes | [44] | |
8 | ADRB2 | Yes | [80] | 3 | BCL2 | Yes | [81] | ||
9 | PLAU | Yes | 4 | GSTP1 | Yes | ||||
10 | B2M | Yes | [86] | 5 | HMOX1 | Yes | [87] | ||
Colon cancer | 1 | MET | Yes | [42] | 6 | ATP6V1B2 | Yes | [88] | |
2 | NOS3 | Yes | [89] | 7 | TP53 | Yes | |||
3 | ESR2 | Yes | [92] | 8 | VEGFA | Yes | [93] |